Navigation Links
Global Patient Safety Highlighted by NABP, Domestic and International Stakeholders at .Pharmacy Supporter Advisory Committee Meeting

MOUNT PROSPECT, Ill., Aug. 5, 2014 /PRNewswire-USNewswire/ -- The National Association of Boards of Pharmacy® (NABP®) welcomed domestic and international stakeholders last week for a meeting of the .Pharmacy Supporter Advisory Committee. The committee's guidance is an important part of operationalizing the new .pharmacy generic Top-Level Domain (gTLD). Members of the committee, which is composed of representatives of domestic and international regulatory agencies and patient safety advocacy groups, as well as technical and industry experts, stressed the importance of implementing standards and policies to support the .pharmacy program's goal to provide patients and consumers around the world a means for identifying safe, legal, and ethical online pharmacies and related resources.

The advisory committee discussed implementation of the .pharmacy standards, including issues related to the international operationalization of the gTLD. International stakeholders, in particular European Alliance for Access to Safe Medicines, International Pharmaceutical Federation, National Association of Pharmacy Regulatory Authorities, and Ordre National des Pharmaciens, shared their expertise on regulatory and pharmacy practice matters. NABP will continue to collaborate with advisory committee members, particularly its international members, to ensure that global implementation of the .pharmacy gTLD meets the unique laws and concerns of each jurisdiction in which the domain is used. The advisory committee meeting followed NABP's execution of a Registry Agreement with the Internet Corporation for Assigned Names and Numbers on June 19, 2014, to become the registry operator for the new .pharmacy gTLD.

NABP plans to launch the .pharmacy gTLD by fall 2014, and, working closely with the .Pharmacy Supporter Advisory Committee, will implement policies to ensure that only legitimate website operators that adhere to pharmacy laws in the jurisdictions in which they are based and to which they sell medicine will be able to register domain names in .pharmacy. For example, a pharmacy that is licensed in another country and is selling prescription drugs to patients in the United States would not be eligible for .pharmacy because it is violating US federal law that prohibits importation. Similarly, Internet pharmacies dispensing prescription medications to patients in France would not be eligible for the .pharmacy domain because French law prohibits the online sale of prescription drugs. The .pharmacy eligibility requirements were developed to address concerns shared by domestic and international stakeholders about illegal online drug sellers distributing products that endanger patient health worldwide.

NABP continues to monitor websites selling prescription drugs to patients in the US and, as of July 2014, has reviewed over 10,780 Internet drug outlets and found 97% of them to be out of compliance with pharmacy laws and practice standards established in the US to protect the public health. Of the 10,434 websites identified as Not Recommended, nearly half offer foreign or non-Food and Drug Administration (FDA)-approved drugs, many of which may be dangerous counterfeits, to unsuspecting US patients. Further, health and regulatory agencies in the US and abroad have reported cases of patients harmed by counterfeit, substandard, and adulterated medications distributed by illegal Internet sellers.

Among the global coalition of stakeholders behind the .pharmacy initiative are the Alliance for Safe Online Pharmacies, Eli Lilly and Company, European Alliance for Access to Safe Medicines, FDA, Gilead Sciences, Inc, International Pharmaceutical Federation, INTERPOL, Janssen Pharmaceuticals, Inc, LegitScript, Merck & Co, Inc, National Association of Pharmacy Regulatory Authorities, Pfizer, and state boards of pharmacy.

More information about NABP and the .Pharmacy gTLD Program, including program updates and a request-for-information form for entities seeking a .pharmacy gTLD, is available at

NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.

SOURCE National Association of Boards of Pharmacy
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology:
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):